For more than 20 years, Roche and Genentech have helped lay the scientific groundwork for personalised healthcare with treatments that target the underlying biology of cancer and other diseases.

Now we are working on taking personalised healthcare toward a future in which treatments are targeted to an individual’s needs and unique genetic profile. Our personalised healthcare partnering strategy is built around identifying strategic partners with whom we can pursue this vision. With Flatiron and Foundation Medicine as part of the Roche Group we are shaping new ways of realising the promise of personalised healthcare.

• Robust data sets

• Advanced Analytics (artificial intelligence including machine learning and deep-learning models)

• Digital and mobile technologies

If you have an opportunity for collaboration or an interesting technology, or if you have an asset in one of our areas of interest, we would like to hear from you.